136 related articles for article (PubMed ID: 38615609)
61. Xanthohumol, a prenylated chalcone from Humulus lupulus L., inhibits cholesteryl ester transfer protein.
Hirata H; Takazumi K; Segawa S; Okada Y; Kobayashi N; Shigyo T; Chiba H
Food Chem; 2012 Oct; 134(3):1432-7. PubMed ID: 25005963
[TBL] [Abstract][Full Text] [Related]
62. Dietary resveratrol increases the expression of hepatic 7α-hydroxylase and ameliorates hypercholesterolemia in high-fat fed C57BL/6J mice.
Chen Q; Wang E; Ma L; Zhai P
Lipids Health Dis; 2012 May; 11():56. PubMed ID: 22607622
[TBL] [Abstract][Full Text] [Related]
63. Comparison of angiopoietin-like protein 3 and 4 reveals structural and mechanistic similarities.
Gunn KH; Gutgsell AR; Xu Y; Johnson CV; Liu J; Neher SB
J Biol Chem; 2021; 296():100312. PubMed ID: 33482195
[TBL] [Abstract][Full Text] [Related]
64. The Angiopoietin-Like Protein 3 and 8 Complex Interacts with Lipoprotein Lipase and Induces LPL Cleavage.
Jin N; Matter WF; Michael LF; Qian Y; Gheyi T; Cano L; Perez C; Lafuente C; Broughton HB; Espada A
ACS Chem Biol; 2021 Mar; 16(3):457-462. PubMed ID: 33656326
[TBL] [Abstract][Full Text] [Related]
65. ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering Targets.
Akoumianakis I; Zvintzou E; Kypreos K; Filippatos TD
Curr Atheroscler Rep; 2021 Mar; 23(5):20. PubMed ID: 33694000
[TBL] [Abstract][Full Text] [Related]
66. Angptl3-null mice show low plasma lipid concentrations by enhanced lipoprotein lipase activity.
Fujimoto K; Koishi R; Shimizugawa T; Ando Y
Exp Anim; 2006 Jan; 55(1):27-34. PubMed ID: 16508209
[TBL] [Abstract][Full Text] [Related]
67. Metabolism of xanthohumol and isoxanthohumol, prenylated flavonoids from hops (Humulus lupulus L.), by human liver microsomes.
Nikolic D; Li Y; Chadwick LR; Pauli GF; van Breemen RB
J Mass Spectrom; 2005 Mar; 40(3):289-99. PubMed ID: 15712367
[TBL] [Abstract][Full Text] [Related]
68. Ligand-activated PPARbeta efficiently represses the induction of LXR-dependent promoter activity through competition with RXR.
Matsusue K; Miyoshi A; Yamano S; Gonzalez FJ
Mol Cell Endocrinol; 2006 Aug; 256(1-2):23-33. PubMed ID: 16806672
[TBL] [Abstract][Full Text] [Related]
69. SREBP-1 and LXRα pathways mediated Cu-induced hepatic lipid metabolism in zebrafish Danio rerio.
Pan YX; Zhuo MQ; Li DD; Xu YH; Wu K; Luo Z
Chemosphere; 2019 Jan; 215():370-379. PubMed ID: 30336314
[TBL] [Abstract][Full Text] [Related]
70. Regulation of energy balance by the hypothalamic lipoprotein lipase regulator Angptl3.
Kim HK; Shin MS; Youn BS; Kang GM; Gil SY; Lee CH; Choi JH; Lim HS; Yoo HJ; Kim MS
Diabetes; 2015 Apr; 64(4):1142-53. PubMed ID: 25338813
[TBL] [Abstract][Full Text] [Related]
71. In Silico Description of the Direct Inhibition Mechanism of Endothelial Lipase by ANGPTL3.
Montavoci L; Ben Mariem O; Saporiti S; Laurenzi T; Palazzolo L; Ossoli AF; Guerrini U; Calabresi L; Eberini I
Int J Mol Sci; 2024 Mar; 25(6):. PubMed ID: 38542527
[TBL] [Abstract][Full Text] [Related]
72. Angiopoietin-like 3 regulates hepatocyte proliferation and lipid metabolism in zebrafish.
Lee SH; So JH; Kim HT; Choi JH; Lee MS; Choi SY; Kim CH; Kim MJ
Biochem Biophys Res Commun; 2014 Apr; 446(4):1237-42. PubMed ID: 24685482
[TBL] [Abstract][Full Text] [Related]
73. Inactivation of ANGPTL3 reduces hepatic VLDL-triglyceride secretion.
Wang Y; Gusarova V; Banfi S; Gromada J; Cohen JC; Hobbs HH
J Lipid Res; 2015 Jul; 56(7):1296-307. PubMed ID: 25954050
[TBL] [Abstract][Full Text] [Related]
74. Angiopoietin-like protein 8 differentially regulates ANGPTL3 and ANGPTL4 during postprandial partitioning of fatty acids.
Chen YQ; Pottanat TG; Siegel RW; Ehsani M; Qian YW; Zhen EY; Regmi A; Roell WC; Guo H; Luo MJ; Gimeno RE; Van't Hooft F; Konrad RJ
J Lipid Res; 2020 Aug; 61(8):1203-1220. PubMed ID: 32487544
[TBL] [Abstract][Full Text] [Related]
75. A hepatokine derived from the ER protein CREBH promotes triglyceride metabolism by stimulating lipoprotein lipase activity.
Kim H; Song Z; Zhang R; Davies BSJ; Zhang K
Sci Signal; 2023 Jan; 16(768):eadd6702. PubMed ID: 36649378
[TBL] [Abstract][Full Text] [Related]
76. Role of angiopoietin-like 3 (ANGPTL3) in regulating plasma level of low-density lipoprotein cholesterol.
Xu YX; Redon V; Yu H; Querbes W; Pirruccello J; Liebow A; Deik A; Trindade K; Wang X; Musunuru K; Clish CB; Cowan C; Fizgerald K; Rader D; Kathiresan S
Atherosclerosis; 2018 Jan; 268():196-206. PubMed ID: 29183623
[TBL] [Abstract][Full Text] [Related]
77. Cross-talk between peroxisome proliferator-activated receptor (PPAR) alpha and liver X receptor (LXR) in nutritional regulation of fatty acid metabolism. II. LXRs suppress lipid degradation gene promoters through inhibition of PPAR signaling.
Ide T; Shimano H; Yoshikawa T; Yahagi N; Amemiya-Kudo M; Matsuzaka T; Nakakuki M; Yatoh S; Iizuka Y; Tomita S; Ohashi K; Takahashi A; Sone H; Gotoda T; Osuga J; Ishibashi S; Yamada N
Mol Endocrinol; 2003 Jul; 17(7):1255-67. PubMed ID: 12730332
[TBL] [Abstract][Full Text] [Related]
78. Metabolic profiling of angiopoietin-like protein 3 and 4 inhibition: a drug-target Mendelian randomization analysis.
Wang Q; Oliver-Williams C; Raitakari OT; Viikari J; Lehtimäki T; Kähönen M; Järvelin MR; Salomaa V; Perola M; Danesh J; Kettunen J; Butterworth AS; Holmes MV; Ala-Korpela M
Eur Heart J; 2021 Mar; 42(12):1160-1169. PubMed ID: 33351885
[TBL] [Abstract][Full Text] [Related]
79. Genetic inhibition of angiopoietin-like protein-3, lipids, and cardiometabolic risk.
Gobeil É; Bourgault J; Mitchell PL; Houessou U; Gagnon E; Girard A; Paulin A; Manikpurage HD; Côté V; Couture C; Marceau S; Bossé Y; Thériault S; Mathieu P; Vohl MC; Tchernof A; Arsenault BJ
Eur Heart J; 2024 Mar; 45(9):707-721. PubMed ID: 38243829
[TBL] [Abstract][Full Text] [Related]
80. A novel fully human anti-NT-ANGPTL3 antibody from phage display library exhibits potent ApoB, TG, and LDL-C lowering activities in hyperlipidemia mice.
Zhang P; Wang K; Hu T; Xu M; You X; Chen M; Tang X; Hu H; Jiang Y; Zhao W; Tan S
FASEB J; 2024 Jan; 38(1):e23399. PubMed ID: 38174870
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
